{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:43Z","timestamp":1793982283274,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41409-026-03010-z","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:59:33Z","timestamp":1787047173000},"page":"1480-1486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8286-4512","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Bili\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-9507","authenticated-orcid":false,"given":"Marcin","family":"Jasi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Krasnod\u0119bska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-8180","authenticated-orcid":false,"given":"Grzegorz W.","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Polge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Boreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-4136","authenticated-orcid":false,"given":"Alexander","family":"Kulagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-1269","authenticated-orcid":false,"given":"Oleg","family":"Goloshchapov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-3863","authenticated-orcid":false,"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Halaburda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-1749","authenticated-orcid":false,"given":"Christine","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-499X","authenticated-orcid":false,"given":"Alina","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Lipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-7834","authenticated-orcid":false,"given":"Gwendolyn","family":"van Gorkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Kerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-036X","authenticated-orcid":false,"given":"Alberto","family":"Mussetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-7305","authenticated-orcid":false,"given":"Charlotte E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-8239","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Schoemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-0114","authenticated-orcid":false,"given":"Ivan","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1447-7286","authenticated-orcid":false,"given":"Katharina","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5799","authenticated-orcid":false,"given":"Krzysztof","family":"Ka\u0142wak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-802X","authenticated-orcid":false,"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinaida","family":"Peri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"3010_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","volume":"18","author":"PJ Martin","year":"2012","unstructured":"Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2012;18:1150\u201363.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3010_CR2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091\u2013101.","journal-title":"N Engl J Med"},{"key":"3010_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/601953","volume":"2011","author":"JR Westin","year":"2011","unstructured":"Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, et al. Steroid-Refractory Acute GVHD: Predictors and Outcomes. Adv Hematol. 2011;2011:601953.","journal-title":"Adv Hematol"},{"key":"3010_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3324\/haematol.2016.156356","volume":"102","author":"HJ Khoury","year":"2017","unstructured":"Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, et al. Improved survival after acute graft-versus-host disease diagnosis in the modern era. Haematologica. 2017;102:958\u201366.","journal-title":"Haematologica"},{"key":"3010_CR5","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2015-10-612747","volume":"127","author":"GB McDonald","year":"2016","unstructured":"McDonald GB. How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. Blood. 2016;127:1544\u201350.","journal-title":"Blood"},{"key":"3010_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. N Engl J Med. 2020;382:1800\u201310.","journal-title":"N Engl J Med"},{"key":"3010_CR7","first-page":"1545","volume":"95","author":"J Bili\u0144ski","year":"2020","unstructured":"Bili\u0144ski J, Lis K, Tomaszewska A, Grzesiowski P, Dzieciatkowski T, Tyszka M, et al. Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter study. Am J Hematol. 2020;95:1545\u201353.","journal-title":"Am J Hematol"},{"key":"3010_CR8","doi-asserted-by":"publisher","first-page":"E461","DOI":"10.1002\/ajh.26365","volume":"96","author":"J Bili\u0144ski","year":"2021","unstructured":"Bili\u0144ski J, Jasi\u0144ski M, Tomaszewska A, Lis K, Kacprzyk P, Chmielewska L, et al. Fecal microbiota transplantation with ruxolitinib as a treatment modality for steroid-refractory\/dependent acute, gastrointestinal graft-versus-host disease: A case series. Am J Hematol. 2021;96:E461\u2013E463.","journal-title":"Am J Hematol"},{"key":"3010_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41409-022-01824-1","volume":"58","author":"X Qiao","year":"2023","unstructured":"Qiao X, Bili\u0144ski J, Wang L, Yang T, Luo R, Fu Y, et al. Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease. Bone Marrow Transpl. 2023;58:10\u201319.","journal-title":"Bone Marrow Transpl"},{"key":"3010_CR10","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1182\/blood-2024-201251","volume":"144","author":"F Malard","year":"2024","unstructured":"Malard F, Loschi M, Cluzeau T, Devillier R, Legrand F, Charbonnier A, et al. Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from Early Access Program in Europe. Blood. 2024;144:4903.","journal-title":"Blood"},{"key":"3010_CR11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5603\/ahp.96754","volume":"54","author":"K Czy\u017cewski","year":"2023","unstructured":"Czy\u017cewski K. Fecal microbiota transplantation for the treatment of chronic graft versus host. Acta Haematol Pol. 2023;54:332\u20134.","journal-title":"Acta Haematol Pol"},{"key":"3010_CR12","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/bloodadvances.2024012556","volume":"8","author":"Z DeFilipp","year":"2024","unstructured":"DeFilipp Z, Damania AV, Kim HT, Chang C, El-Jawahri A, McAfee SL, et al. Third-party fecal microbiota transplantation for high-risk treatment-na\u00efve acute GVHD of the lower GI tract. Blood Adv. 2024;8:2074\u201384.","journal-title":"Blood Adv"},{"key":"3010_CR13","first-page":"59","volume":"13","author":"B Borgstrom","year":"1994","unstructured":"Borgstrom B, Bolme P. Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transpl. 1994;13:59\u201364.","journal-title":"Bone Marrow Transpl"},{"key":"3010_CR14","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1182\/blood-2024-210774","volume":"144","author":"JE Lim","year":"2024","unstructured":"Lim JE, Madabushi SS, Shukare ML, Ghimire H, Paredes J, Mokhtari S, et al. Tissue-Specific Myeloablative Conditioning with Total Marrow Irradiation Enhances Gut Microbiome Diversity and Mitigates Gvhd: A Novel Therapeutic Approach. Blood. 2024;144:3393.","journal-title":"Blood"},{"key":"3010_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood.2023022865","volume":"143","author":"P Khandelwal","year":"2024","unstructured":"Khandelwal P, Langenberg L, Luebbering N, Lake KE, Butcher A, Bota K, et al. A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults. Blood. 2024;143:1181\u201392.","journal-title":"Blood"},{"key":"3010_CR16","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/s41591-024-03016-4","volume":"30","author":"YB Chen","year":"2024","unstructured":"Chen YB, Mohty M, Zeiser R, Teshima T, Jamy O, Maertens J, et al. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nat Med. 2024;30:2277\u201387.","journal-title":"Nat Med"},{"key":"3010_CR17","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Kao D, Roach B, Silva M, Beck P, Rioux K, Kaplan GG, et al. Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2017;318:1985\u201393.","journal-title":"JAMA"},{"key":"3010_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407\u201315.","journal-title":"N Engl J Med"},{"key":"3010_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/apt.14201","volume":"46","author":"MN Quraishi","year":"2017","unstructured":"Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479\u201393.","journal-title":"Aliment Pharmacol Ther"},{"key":"3010_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cid\/cix252","volume":"65","author":"J Bili\u0144ski","year":"2017","unstructured":"Bili\u0144ski J, Grzesiowski P, Sorensen N, M\u0105dry K, Muszy\u0144ski J, Robak K, et al. Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study. Clin Infect Dis. 2017;65:364\u201370.","journal-title":"Clin Infect Dis"},{"key":"3010_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.20953\/1729-9225-2017-3-65-74","volume":"15","author":"O Goloshchapov","year":"2017","unstructured":"Goloshchapov O, Kucher M, Sovorova M, Klement\u2019eva RV, Scherbakov AA, Shvetsov AN, et al. A first experience of therapy of multi-resistant infectious complications associated with Clostridium difficile and Klebsiella pneumoniae, using a method of fecal microbiota transplantation in patients after allogeneic hemopoietic stem cell transplantation. Infekcionnye Bolezni. 2017;15:65\u201374.","journal-title":"Infekcionnye Bolezni"},{"key":"3010_CR22","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1182\/blood-2024-204750","volume":"144","author":"BH Mullish","year":"2024","unstructured":"Mullish BH, Innes AJ, Ghani R, Anim-Burton S, Webber L, Wheeler G, et al. Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST): A Multi-Center Randomized Double-Blinded Placebo-Controlled Phase IIa Trial. Blood. 2024;144:4892.","journal-title":"Blood"},{"key":"3010_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56336-3","volume":"14","author":"A Piekarska","year":"2024","unstructured":"Piekarska A, Sadowska-Klasa A, Mensah-Glanowska P, Sobczyk-Kruszelnicka M, Drozd-Soko\u0142owska J, Waszczuk-Gajda A, et al. Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group. Sci Rep. 2024;14:5947.","journal-title":"Sci Rep"},{"key":"3010_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhin.2024.03.001","volume":"148","author":"BH Mullish","year":"2024","unstructured":"Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2024;148:189\u2013219.","journal-title":"J Hosp Infect"},{"key":"3010_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","volume":"166","author":"AF Peery","year":"2024","unstructured":"Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, et al. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024;166:409\u201334.","journal-title":"Gastroenterology"},{"key":"3010_CR26","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1182\/blood-2021-147777","volume":"138","author":"F Huang","year":"2021","unstructured":"Huang F, Lv P, Liu Q. Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Acute and Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation. Blood. 2021;138:4884.","journal-title":"Blood"},{"key":"3010_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"3010_CR28","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.14309\/01.ajg.0000590336.17703.14","volume":"114","author":"R Tariq","year":"2019","unstructured":"Tariq R, Furqan F, Pardi DS, Khanna S. Efficacy of Fecal Microbiota Transplantation for Acute Graft Versus Host Disease in the Gut: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019;114:S123.","journal-title":"Am J Gastroenterol"},{"key":"3010_CR29","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/bloodadvances.2024012561","volume":"8","author":"Z DeFilipp","year":"2024","unstructured":"DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, et al. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood Adv. 2024;8:3488\u201396.","journal-title":"Blood Adv"},{"key":"3010_CR30","first-page":"220","volume":"58","author":"A Gaballa","year":"2023","unstructured":"Gaballa A, Kohorst M, Litzow M, Hogan WJ, Kremers WK, Inwards DJ, et al. Ruxolitinib with extracorporeal photopheresis for the treatment of steroid-refractory acute graft-versus-host disease. Bone Marrow Transpl. 2023;58:220\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"3010_CR31","first-page":"268.e1","volume":"27","author":"RS Mehta","year":"2021","unstructured":"Mehta RS, Saliba RM, Jan A, Chen J, Rondon G, Alousi AM, et al. Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease. Transpl Cell Ther. 2021;27:268.e1\u2013268.e5.","journal-title":"Transpl Cell Ther"},{"key":"3010_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1408211","volume":"15","author":"Z Gao","year":"2024","unstructured":"Gao Z, Fan Z, Liu Z, Ye X, Zeng Y, Xuan L, et al. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease. Front Immunol. 2024;15:1408211.","journal-title":"Front Immunol"},{"key":"3010_CR33","first-page":"5372","volume":"4","author":"J Magenau","year":"2020","unstructured":"Magenau J, Peltier D, Riwes M, Fasan O, Nakasone H, Mielcarek M, et al. Alpha-1-antitrypsin for the treatment of steroid-refractory acute graft-versus-host disease. Blood Adv. 2020;4:5372\u201381.","journal-title":"Blood Adv"},{"key":"3010_CR34","unstructured":"MaaT Pharma. MaaT Pharma Announces Positive Topline Results from the Pivotal Phase 3 ARES Study Evaluating MaaT013 in Acute Graft-versus-Host Disease [Internet]. Lyon: MaaT Pharma; 2025. Available from: https:\/\/www.maatpharma.com\/january-8-2025-maat-pharma-announces-positive-topline-results-from-the-pivotal-phase-3-ares-study-evaluating-maat013-in-acute-graft-versus-host-disease\/"},{"key":"3010_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature16460","volume":"528","author":"CA Lindemans","year":"2015","unstructured":"Lindemans CA, Calafiore M, Mertelsmann AM, O\u2019Connor MH, Dudakov JA, Jenq RR, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560\u20134.","journal-title":"Nature"},{"key":"3010_CR36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood.2020005957","volume":"136","author":"SC Nalle","year":"2020","unstructured":"Nalle SC, Turner D, Ranganathan P, Wang H, Sato T, Jenq RR, et al. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. Blood. 2020;136:1442\u201355.","journal-title":"Blood"},{"key":"3010_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020;382:822\u201334.","journal-title":"N Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03010-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:36Z","timestamp":1793978856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03010-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3010"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-03010-z","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JB and GB are the owners of Human Biome Institute \u2013 a microbiota therapeutics company. HS reports having received personal fees from Incyte, Novartis, Sanofi, MAAT Pharma and from the Belgian Hematological Society (BHS), as well as research grants from Novartis, Sanofi and the BHS, all paid to her institution. She has also received non-financial support from Gilead, Pfizer, Sanofi, AbbVie, the EBMT (European Society for Blood and Marrow transplantation) and the CIBMTR (Center for International Bone Marrow Transplantation Research). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"As this was a retrospective survey study, the Internal Review Boards of the CWP and PDWP of the EBMT agreed to pursue the study. Originally, every participating Center had their local Ethical Committees positive opinions.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}